Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease (Q35377706)

8 August 2017

0 references

1 reference

title

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease (English)

1 reference

8 August 2017

main subject

cardiovascular disease

1 reference

1 reference

1 reference

1 reference

Fumiaki Imamura

2

0 references

Dariush Mozaffarian

series ordinal

7

object named as

Dariush Mozaffarian

1 reference

8 August 2017

6

Paul M Ridker

1 reference

8 August 2017

4

Daniel H Solomon

1 reference

8 August 2017

1

Renata Micha

1 reference

8 August 2017

5

Miguel A Hernán

1 reference

8 August 2017

author name string

Moritz Wyler von Ballmoos

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

17 August 2011

1 reference

American Journal of Cardiology

8 August 2017

published in

1 reference

8 August 2017

volume

108

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

1362-1370

1 reference

Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Effects of methotrexate on plasma cytokines and cardiac remodeling and function in postmyocarditis rats.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Cardiovascular manifestations of rheumatologic diseases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Patterns of cardiovascular risk in rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Inflammatory markers and the risk of coronary heart disease in men and women

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Safety of low dose methotrexate in elderly patients with rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Bias in meta-analysis detected by a simple, graphical test

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Operating characteristics of a rank correlation test for publication bias

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Meta-analysis in clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196048

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

26 September 2018

1 reference

12 December 2020

Cause of death in rheumatoid arthritis

1 reference

12 December 2020

Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial

1 reference

12 December 2020

Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis

1 reference

12 December 2020

Antirheumatic drug use and the risk of acute myocardial infarction

1 reference

12 December 2020

Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis

1 reference

12 December 2020

10.1016/J.AMJCARD.2011.06.054

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference